JW Pharmaceutical Corporation (001060.KS)
- Previous Close
30,500.00 - Open
30,450.00 - Bid --
- Ask --
- Day's Range
29,750.00 - 30,500.00 - 52 Week Range
20,980.39 - 51,470.59 - Volume
46,401 - Avg. Volume
139,382 - Market Cap (intraday)
697.278B - Beta (5Y Monthly) 0.61
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 8, 2024 - May 13, 2024
- Forward Dividend & Yield 400.00 (1.31%)
- Ex-Dividend Date Dec 27, 2023
- 1y Target Est
45,373.00
JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is based in Gwacheon-si, South Korea.
www.jw-pharma.co.kr--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: 001060.KS
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 001060.KS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 001060.KS
Valuation Measures
Market Cap
713.66B
Enterprise Value
793.75B
Trailing P/E
20.28
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.00
Price/Book (mrq)
2.71
Enterprise Value/Revenue
1.06
Enterprise Value/EBITDA
8.82
Financial Highlights
Profitability and Income Statement
Profit Margin
4.94%
Return on Assets (ttm)
9.49%
Return on Equity (ttm)
15.65%
Revenue (ttm)
748.53B
Net Income Avi to Common (ttm)
37.01B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
94.2B
Total Debt/Equity (mrq)
64.15%
Levered Free Cash Flow (ttm)
23.38B
Research Analysis: 001060.KS
Company Insights: 001060.KS
001060.KS does not have Company Insights